Account
Webinar
08.12.2022
Are you ready for the new EU HTA in 2025?

Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...

Read more
30.11.2022
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
Articles
03.08.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

Our Market Access analysts summarise the EUnetHTA draft scoping process and provide considerations a...

Read more
Articles
28.06.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

The EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...

Read more
Articles
22.06.2022
EU Joint HTA: How should manufacturers adapt to th...

EUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...

Read more
Articles
21.06.2022
Seeking early advice from the EMA and multiple HTA...

Introduction Achieving access to patients for innovative treatments is becoming a significant challe...

Read more
Articles
07.06.2022
EU Joint HTA: What’s going on and what does it m...

EUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...

Read more
Articles
17.11.2021
Head of agencies HAG

The Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...

Read more
Articles
14.07.2021
Market Access News Summary

We’ve prepared a summary of our key market access blogs and news articles from the second quarter ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.